Ferozsons Laboratories Limited

KASE:FEROZ Stock Report

Market Cap: PK₨14.1b

Ferozsons Laboratories Past Earnings Performance

Past criteria checks 4/6

Ferozsons Laboratories's earnings have been declining at an average annual rate of -0.5%, while the Pharmaceuticals industry saw earnings growing at 3.4% annually. Revenues have been growing at an average rate of 20.7% per year. Ferozsons Laboratories's return on equity is 5.9%, and it has net margins of 4%.

Key information

-0.5%

Earnings growth rate

-0.5%

EPS growth rate

Pharmaceuticals Industry Growth20.2%
Revenue growth rate20.7%
Return on equity5.9%
Net Margin4.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Ferozsons Laboratories makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KASE:FEROZ Revenue, expenses and earnings (PKR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2415,9556404,7160
30 Jun 2415,8556834,6060
31 Mar 2415,1364944,3210
31 Dec 2314,5163953,8540
30 Sep 2313,3194083,5910
30 Jun 2311,4572713,2050
31 Mar 2310,7431643,1850
31 Dec 2210,1734093,0450
30 Sep 229,6745872,8350
30 Jun 229,3307342,6510
31 Mar 229,7881,2632,5560
31 Dec 219,5821,2652,4140
30 Sep 219,5931,3302,2360
30 Jun 218,8791,1732,0850
31 Mar 217,6199171,7300
31 Dec 207,0497371,6800
30 Sep 206,3854561,7240
30 Jun 206,2124171,7050
31 Mar 206,3743351,8660
31 Dec 196,0002481,8650
30 Sep 195,9262071,7790
30 Jun 195,8032011,7180
31 Mar 195,249771,6140
31 Dec 185,162831,5930
30 Sep 185,180161,5490
30 Jun 185,00371,4800
31 Mar 185,111-321,4890
31 Dec 174,8362131,3830
30 Sep 174,7072441,3270
30 Jun 175,0023961,3400
31 Mar 175,6676691,4500
31 Dec 167,4949171,5070
30 Sep 169,6021,6751,5720
30 Jun 1611,2952,2041,5470
31 Mar 1611,3902,3431,4110
31 Dec 1510,1132,1211,3080
30 Sep 157,8601,5281,2180
30 Jun 155,7119051,1770
31 Mar 154,6896971,1410
31 Dec 144,0515731,1150
30 Sep 143,8255421,0720
30 Jun 143,8325261,0380
31 Mar 143,6405799400
31 Dec 133,3795059120

Quality Earnings: FEROZ has high quality earnings.

Growing Profit Margin: FEROZ's current net profit margins (4%) are higher than last year (3.1%).

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: FEROZ's earnings have declined by 0.5% per year over the past 5 years.

Accelerating Growth: FEROZ's earnings growth over the past year (57%) exceeds its 5-year average (-0.5% per year).

Earnings vs Industry: FEROZ earnings growth over the past year (57%) exceeded the Pharmaceuticals industry 56%.

Return on Equity

High ROE: FEROZ's Return on Equity (5.9%) is considered low.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:24
End of Day Share Price 2024/12/23 00:00
Earnings2024/09/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Ferozsons Laboratories Limited is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullInsight Securities (Private) Limited
Naima AliShajar Capital Pakistan (Private) Limited